State Street’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Sell |
2,689,686
-17,013
| -0.6% | -$111K | ﹤0.01% | 2263 |
|
|
2025
Q1 | $21.5M | Sell |
2,706,699
-394,978
| -13% | -$3.13M | ﹤0.01% | 2105 |
|
|
2024
Q4 | $39.3M | Buy |
3,101,677
+277,860
| +10% | +$3.52M | ﹤0.01% | 1845 |
|
|
2024
Q3 | $39.3M | Sell |
2,823,817
-3,003
| -0.1% | -$41.8K | ﹤0.01% | 1824 |
|
|
2024
Q2 | $39M | Sell |
2,826,820
-68,063
| -2% | -$938K | ﹤0.01% | 1790 |
|
|
2024
Q1 | $47.8M | Sell |
2,894,883
-485,215
| -14% | -$8.02M | ﹤0.01% | 1749 |
|
|
2023
Q4 | $49.3M | Buy |
3,380,098
+444,179
| +15% | +$6.49M | ﹤0.01% | 1710 |
|
|
2023
Q3 | $36M | Sell |
2,935,919
-418,407
| -12% | -$5.13M | ﹤0.01% | 1811 |
|
|
2023
Q2 | $40.1M | Buy |
3,354,326
+1,097,535
| +49% | +$13.1M | ﹤0.01% | 1804 |
|
|
2023
Q1 | $30.2M | Sell |
2,256,791
-199,744
| -8% | -$2.67M | ﹤0.01% | 1964 |
|
|
2022
Q4 | $52.9M | Buy |
2,456,535
+414,797
| +20% | +$8.93M | ﹤0.01% | 1601 |
|
|
2022
Q3 | $40.9M | Buy |
2,041,738
+1,682,955
| +469% | +$33.7M | ﹤0.01% | 1744 |
|
|
2022
Q2 | $6.42M | Buy |
358,783
+142,567
| +66% | +$2.55M | ﹤0.01% | 2968 |
|
|
2022
Q1 | $2.15M | Buy |
216,216
+26,725
| +14% | +$265K | ﹤0.01% | 3540 |
|
|
2021
Q4 | $3.19M | Buy |
189,491
+65,459
| +53% | +$1.1M | ﹤0.01% | 3467 |
|
|
2021
Q3 | $2.94M | Buy |
+124,032
| New | +$2.94M | ﹤0.01% | 3500 |
|